Celebrating 13 Years of Nonprofit Independence
Are Any of Us Safe from Faulty Generics?

Are Any of Us Safe from Faulty Generics?

Tuesday, October 28, 2025 . 8:00 am 60 min

Americans are waking up to the fact that we’ve been tolerating unacceptable failure rates for drugs that are supposed to be safe and effective.

Featuring:
– Reshma Ramachandran, M.D., Assistant Professor of Medicine and Co-Director of Yale CRRIT, Yale School of Medicine
– Marta Wosińska, Ph.D., Senior Fellow, Center on Health Policy, The Brookings Institution
– Emma Yasinski, Senior Reporter, MedShadow Foundation (moderator)

Join this discussion that examines the changes and incentives needed to improve the drug system’s quality control and supply chains, and ensure everyone can access safe, reliable generic drugs.

Webinar Series: Investigating Generic Drugs

Related Content

How Poor Quality Generic Drugs Cause Harm

If you feel like your generic drugs aren’t working, you may be right. Generics don’t alway...

Mending the Tattered Safety Net of the FDA

Low-quality generics are being sold at U.S. pharmacies, despite the FDA’s best efforts. In...

What is unbiased drug-safety journalism worth to you?

We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.

What is Unbiased Drug-Safety Journalism Worth to You?

We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.

As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.

Comments

No comments yet. Be the first to comment!